Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-09-11

AUTHORS

D. Cheng, E. Liu, Y. Li, R. Liu, L. Bai, Y. Chen, Y. Wang, Y. Chu, M. Wu, G. Cheng, S. Zhao

ABSTRACT

Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81 % vs. 64 %, respectively; odds ratio, 2.60; 95 % confidence interval: 1.32–5.14; p < 0.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80 % vs. 70 %, respectively), a viral response at week 24 of treatment (82 % vs. 73 %, respectively), and end-of-treatment viral response (ETVR, 73 % vs. 62 %, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53 % vs. 57 %, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone. More... »

PAGES

433-438

References to SciGraph publications

  • 2010-09-09. Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y

    DOI

    http://dx.doi.org/10.1007/s10096-013-1973-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044778033

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24022094


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Therapy, Combination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drugs, Chinese Herbal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hepatitis C, Chronic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferon alpha-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferon-alpha", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polyethylene Glycols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cheng", 
            "givenName": "D.", 
            "id": "sg:person.0656247150.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "E.", 
            "id": "sg:person.016446245112.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Li", 
            "givenName": "Y.", 
            "id": "sg:person.01101266316.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "R.", 
            "id": "sg:person.0641103675.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641103675.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bai", 
            "givenName": "L.", 
            "id": "sg:person.0707217075.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707217075.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chen", 
            "givenName": "Y.", 
            "id": "sg:person.0720253721.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Y.", 
            "id": "sg:person.0604025321.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Molecular Virology, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Institute of Molecular Virology, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chu", 
            "givenName": "Y.", 
            "id": "sg:person.01132665065.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wu", 
            "givenName": "M.", 
            "id": "sg:person.0610133750.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610133750.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cheng", 
            "givenName": "G.", 
            "id": "sg:person.0722565616.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722565616.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "S.", 
            "id": "sg:person.01217761561.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10096-010-1051-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048534807", 
              "https://doi.org/10.1007/s10096-010-1051-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-09-11", 
        "datePublishedReg": "2013-09-11", 
        "description": "Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81\u00a0% vs. 64\u00a0%, respectively; odds ratio, 2.60; 95\u00a0% confidence interval: 1.32\u20135.14; p\u2009<\u20090.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80\u00a0% vs. 70\u00a0%, respectively), a viral response at week 24 of treatment (82\u00a0% vs. 73\u00a0%, respectively), and end-of-treatment viral response (ETVR, 73\u00a0% vs. 62\u00a0%, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53\u00a0% vs. 57\u00a0%, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s10096-013-1973-y", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1093599", 
            "issn": [
              "0934-9723", 
              "1435-4373"
            ], 
            "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "33"
          }
        ], 
        "keywords": [
          "chronic hepatitis C", 
          "Chinese herbal therapy", 
          "peginterferon therapy", 
          "viral response", 
          "herbal therapy", 
          "virological response", 
          "hepatitis C", 
          "Chinese herbs", 
          "adverse events", 
          "combined therapy", 
          "treatment of CHC", 
          "treatment viral response", 
          "alanine transaminase normalization", 
          "rapid viral response", 
          "high virological response", 
          "Cochrane Central Register", 
          "early viral response", 
          "traditional Chinese herbal therapy", 
          "China National Knowledge Infrastructure", 
          "China Biomedical Database", 
          "National Knowledge Infrastructure", 
          "transaminase normalization", 
          "CHC patients", 
          "Central Register", 
          "week 24", 
          "treat principle", 
          "Controlled Trials", 
          "peginterferon", 
          "Wanfang Database", 
          "current evidence", 
          "therapy", 
          "patients", 
          "Knowledge Infrastructure", 
          "literature search", 
          "Science Citation Index", 
          "biomedical databases", 
          "RCTs", 
          "relapse", 
          "treatment", 
          "trials", 
          "Citation Index", 
          "response", 
          "selection criteria", 
          "herbs", 
          "EMBASE", 
          "MEDLINE", 
          "database", 
          "Asian countries", 
          "study", 
          "Register", 
          "events", 
          "aim", 
          "evidence", 
          "index", 
          "normalization", 
          "criteria", 
          "search", 
          "data", 
          "countries", 
          "end", 
          "intention", 
          "results", 
          "China", 
          "principles", 
          "infrastructure"
        ], 
        "name": "Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C", 
        "pagination": "433-438", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044778033"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10096-013-1973-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24022094"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10096-013-1973-y", 
          "https://app.dimensions.ai/details/publication/pub.1044778033"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_607.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s10096-013-1973-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    269 TRIPLES      21 PREDICATES      107 URIs      98 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10096-013-1973-y schema:about N29da9d7ef26c460da7b9e228cf88d9f7
    2 N3242b75367b74bae9daef44dd1c003ef
    3 N4004177a00884661a03824269bbcdd5e
    4 N52367ae7bde943759841dd6fd44a077e
    5 N6338227d1b5141318555f8d89ee3c067
    6 N688717ac5bf244e1b31336d12828a0db
    7 N781604c2ff84488baf3c5249f6153b3d
    8 N7c7045319267430594c2139b4019c29f
    9 N85d760eb109c4653b007ef986579efbe
    10 N86359a1446054a22a9a8d65f8e30c29c
    11 N90244233df6d4c91a744a29ff0cd7f19
    12 N99881d3e321a4b3783f38e0d3adec9a1
    13 Nb1d000efe8c04bd8b6e7a9479470e8c3
    14 Nba8bcc5506da48a78858a1fe536a8819
    15 Nc1b95fd6c6aa41aaaf143992276037f0
    16 Nd532930d92074a95a9fa83b6cb368681
    17 anzsrc-for:11
    18 anzsrc-for:1103
    19 schema:author N28d5ddd7a7444daca89b9c83ab30cf57
    20 schema:citation sg:pub.10.1007/s10096-010-1051-7
    21 schema:datePublished 2013-09-11
    22 schema:datePublishedReg 2013-09-11
    23 schema:description Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81 % vs. 64 %, respectively; odds ratio, 2.60; 95 % confidence interval: 1.32–5.14; p < 0.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80 % vs. 70 %, respectively), a viral response at week 24 of treatment (82 % vs. 73 %, respectively), and end-of-treatment viral response (ETVR, 73 % vs. 62 %, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53 % vs. 57 %, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone.
    24 schema:genre article
    25 schema:isAccessibleForFree false
    26 schema:isPartOf N2b7141a968a44e81bdddfe7a196d1a61
    27 Naf177c569e8e4f97bf9db06b9c8da10d
    28 sg:journal.1093599
    29 schema:keywords Asian countries
    30 CHC patients
    31 Central Register
    32 China
    33 China Biomedical Database
    34 China National Knowledge Infrastructure
    35 Chinese herbal therapy
    36 Chinese herbs
    37 Citation Index
    38 Cochrane Central Register
    39 Controlled Trials
    40 EMBASE
    41 Knowledge Infrastructure
    42 MEDLINE
    43 National Knowledge Infrastructure
    44 RCTs
    45 Register
    46 Science Citation Index
    47 Wanfang Database
    48 adverse events
    49 aim
    50 alanine transaminase normalization
    51 biomedical databases
    52 chronic hepatitis C
    53 combined therapy
    54 countries
    55 criteria
    56 current evidence
    57 data
    58 database
    59 early viral response
    60 end
    61 events
    62 evidence
    63 hepatitis C
    64 herbal therapy
    65 herbs
    66 high virological response
    67 index
    68 infrastructure
    69 intention
    70 literature search
    71 normalization
    72 patients
    73 peginterferon
    74 peginterferon therapy
    75 principles
    76 rapid viral response
    77 relapse
    78 response
    79 results
    80 search
    81 selection criteria
    82 study
    83 therapy
    84 traditional Chinese herbal therapy
    85 transaminase normalization
    86 treat principle
    87 treatment
    88 treatment of CHC
    89 treatment viral response
    90 trials
    91 viral response
    92 virological response
    93 week 24
    94 schema:name Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C
    95 schema:pagination 433-438
    96 schema:productId Nb35844b2016c45218c5ed9e82ff59ad1
    97 Nb4f9783e3320490898778a97c8cfac83
    98 Nc3b03436bc6e433b8aca6b7dd350e151
    99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044778033
    100 https://doi.org/10.1007/s10096-013-1973-y
    101 schema:sdDatePublished 2022-09-02T15:56
    102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    103 schema:sdPublisher N5fb5812ff72c4fc2997030f2f770af6a
    104 schema:url https://doi.org/10.1007/s10096-013-1973-y
    105 sgo:license sg:explorer/license/
    106 sgo:sdDataset articles
    107 rdf:type schema:ScholarlyArticle
    108 N0d126f7484d04274a1261f4aa74a8a3c rdf:first sg:person.01101266316.28
    109 rdf:rest Na908c13cd45e43c08e8fed42301a2dfc
    110 N19cd1cc49ae443438032420e60dafbee rdf:first sg:person.0722565616.77
    111 rdf:rest Ne2842ef24c5d43b7925332dcee4eb9e9
    112 N212d923f2a8d45768b1c7f8378c35389 rdf:first sg:person.01132665065.66
    113 rdf:rest N41d438283b6c47dc9c184eb7f39ce044
    114 N28d5ddd7a7444daca89b9c83ab30cf57 rdf:first sg:person.0656247150.94
    115 rdf:rest Nbef53efadb4641518c153a1c0b337883
    116 N29da9d7ef26c460da7b9e228cf88d9f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Interferon alpha-2
    118 rdf:type schema:DefinedTerm
    119 N2b7141a968a44e81bdddfe7a196d1a61 schema:volumeNumber 33
    120 rdf:type schema:PublicationVolume
    121 N3242b75367b74bae9daef44dd1c003ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Polyethylene Glycols
    123 rdf:type schema:DefinedTerm
    124 N4004177a00884661a03824269bbcdd5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Drugs, Chinese Herbal
    126 rdf:type schema:DefinedTerm
    127 N41d438283b6c47dc9c184eb7f39ce044 rdf:first sg:person.0610133750.71
    128 rdf:rest N19cd1cc49ae443438032420e60dafbee
    129 N52367ae7bde943759841dd6fd44a077e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Interferon-alpha
    131 rdf:type schema:DefinedTerm
    132 N5fb5812ff72c4fc2997030f2f770af6a schema:name Springer Nature - SN SciGraph project
    133 rdf:type schema:Organization
    134 N6338227d1b5141318555f8d89ee3c067 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Middle Aged
    136 rdf:type schema:DefinedTerm
    137 N688717ac5bf244e1b31336d12828a0db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Randomized Controlled Trials as Topic
    139 rdf:type schema:DefinedTerm
    140 N781604c2ff84488baf3c5249f6153b3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Drug Therapy, Combination
    142 rdf:type schema:DefinedTerm
    143 N7c7045319267430594c2139b4019c29f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Adolescent
    145 rdf:type schema:DefinedTerm
    146 N85d760eb109c4653b007ef986579efbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Male
    148 rdf:type schema:DefinedTerm
    149 N86359a1446054a22a9a8d65f8e30c29c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Female
    151 rdf:type schema:DefinedTerm
    152 N90244233df6d4c91a744a29ff0cd7f19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Aged
    154 rdf:type schema:DefinedTerm
    155 N98d05a57a2ed49ae997eff5499a6cc7c rdf:first sg:person.0707217075.15
    156 rdf:rest Na29dc7b162e2439e9b1f4241381a2dde
    157 N99881d3e321a4b3783f38e0d3adec9a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Hepatitis C, Chronic
    159 rdf:type schema:DefinedTerm
    160 Na29dc7b162e2439e9b1f4241381a2dde rdf:first sg:person.0720253721.55
    161 rdf:rest Nb0b13c752ab14f8fb9d7255d4a69cd80
    162 Na908c13cd45e43c08e8fed42301a2dfc rdf:first sg:person.0641103675.96
    163 rdf:rest N98d05a57a2ed49ae997eff5499a6cc7c
    164 Naf177c569e8e4f97bf9db06b9c8da10d schema:issueNumber 3
    165 rdf:type schema:PublicationIssue
    166 Nb0b13c752ab14f8fb9d7255d4a69cd80 rdf:first sg:person.0604025321.87
    167 rdf:rest N212d923f2a8d45768b1c7f8378c35389
    168 Nb1d000efe8c04bd8b6e7a9479470e8c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Recombinant Proteins
    170 rdf:type schema:DefinedTerm
    171 Nb35844b2016c45218c5ed9e82ff59ad1 schema:name doi
    172 schema:value 10.1007/s10096-013-1973-y
    173 rdf:type schema:PropertyValue
    174 Nb4f9783e3320490898778a97c8cfac83 schema:name pubmed_id
    175 schema:value 24022094
    176 rdf:type schema:PropertyValue
    177 Nba8bcc5506da48a78858a1fe536a8819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Adult
    179 rdf:type schema:DefinedTerm
    180 Nbef53efadb4641518c153a1c0b337883 rdf:first sg:person.016446245112.43
    181 rdf:rest N0d126f7484d04274a1261f4aa74a8a3c
    182 Nc1b95fd6c6aa41aaaf143992276037f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Young Adult
    184 rdf:type schema:DefinedTerm
    185 Nc3b03436bc6e433b8aca6b7dd350e151 schema:name dimensions_id
    186 schema:value pub.1044778033
    187 rdf:type schema:PropertyValue
    188 Nd532930d92074a95a9fa83b6cb368681 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Humans
    190 rdf:type schema:DefinedTerm
    191 Ne2842ef24c5d43b7925332dcee4eb9e9 rdf:first sg:person.01217761561.81
    192 rdf:rest rdf:nil
    193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Medical and Health Sciences
    195 rdf:type schema:DefinedTerm
    196 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    197 schema:name Clinical Sciences
    198 rdf:type schema:DefinedTerm
    199 sg:journal.1093599 schema:issn 0934-9723
    200 1435-4373
    201 schema:name European Journal of Clinical Microbiology & Infectious Diseases
    202 schema:publisher Springer Nature
    203 rdf:type schema:Periodical
    204 sg:person.01101266316.28 schema:affiliation grid-institutes:grid.43169.39
    205 schema:familyName Li
    206 schema:givenName Y.
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28
    208 rdf:type schema:Person
    209 sg:person.01132665065.66 schema:affiliation grid-institutes:grid.43169.39
    210 schema:familyName Chu
    211 schema:givenName Y.
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66
    213 rdf:type schema:Person
    214 sg:person.01217761561.81 schema:affiliation grid-institutes:grid.43169.39
    215 schema:familyName Zhao
    216 schema:givenName S.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81
    218 rdf:type schema:Person
    219 sg:person.016446245112.43 schema:affiliation grid-institutes:grid.43169.39
    220 schema:familyName Liu
    221 schema:givenName E.
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43
    223 rdf:type schema:Person
    224 sg:person.0604025321.87 schema:affiliation grid-institutes:grid.43169.39
    225 schema:familyName Wang
    226 schema:givenName Y.
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87
    228 rdf:type schema:Person
    229 sg:person.0610133750.71 schema:affiliation grid-institutes:grid.43169.39
    230 schema:familyName Wu
    231 schema:givenName M.
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610133750.71
    233 rdf:type schema:Person
    234 sg:person.0641103675.96 schema:affiliation grid-institutes:grid.43169.39
    235 schema:familyName Liu
    236 schema:givenName R.
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641103675.96
    238 rdf:type schema:Person
    239 sg:person.0656247150.94 schema:affiliation grid-institutes:grid.43169.39
    240 schema:familyName Cheng
    241 schema:givenName D.
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94
    243 rdf:type schema:Person
    244 sg:person.0707217075.15 schema:affiliation grid-institutes:grid.43169.39
    245 schema:familyName Bai
    246 schema:givenName L.
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707217075.15
    248 rdf:type schema:Person
    249 sg:person.0720253721.55 schema:affiliation grid-institutes:grid.43169.39
    250 schema:familyName Chen
    251 schema:givenName Y.
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55
    253 rdf:type schema:Person
    254 sg:person.0722565616.77 schema:affiliation grid-institutes:grid.43169.39
    255 schema:familyName Cheng
    256 schema:givenName G.
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722565616.77
    258 rdf:type schema:Person
    259 sg:pub.10.1007/s10096-010-1051-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048534807
    260 https://doi.org/10.1007/s10096-010-1051-7
    261 rdf:type schema:CreativeWork
    262 grid-institutes:grid.43169.39 schema:alternateName Institute of Molecular Virology, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    263 Laboratory for Lipid Metabolism and Atherosclerosis, Xi’an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China
    264 The Third Affiliated Hospital of the School of Medicine, Xi’an Jiaotong University, Shaanxi, China
    265 schema:name Institute of Molecular Virology, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    266 Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    267 Laboratory for Lipid Metabolism and Atherosclerosis, Xi’an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China
    268 The Third Affiliated Hospital of the School of Medicine, Xi’an Jiaotong University, Shaanxi, China
    269 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...